70 results
8-K
EX-10.1
ORIC
ORIC Pharmaceuticals Inc
29 Mar 24
Departure of Directors or Certain Officers
4:15pm
in good faith by the Administrator.
The determination of fair market value for purposes of tax withholding may be made in the Administrator’s discretion … or to satisfy the tax withholding obligations related to an Award will become available for future grant or sale under the Plan. To the extent an Award under
S-3ASR
ORIC
ORIC Pharmaceuticals Inc
11 Mar 24
Automatic shelf registration
5:28pm
the name and address of the depositary and will include a discussion of material U.S. federal income tax considerations applicable to the common stock … the warrant agreement and warrants may be modified;
federal income tax consequences of holding or exercising the warrants;
the terms of the securities
S-3ASR
EX-4.2
sde3q42o de8bdwbb
11 Mar 24
Automatic shelf registration
5:28pm
8-K
EX-10.1
r64ly7b 1lyz2
22 Jan 24
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
9:01am
S-3
q8073n4uis l8d
15 Dec 23
Shelf registration
4:32pm
8-K
EX-10.1
0yxsqjt3qqr6ha1d98
27 Jun 23
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
6:05am
8-K
EX-4.1
e44dku0i8fqy6eo2qs
27 Jun 23
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
6:05am
8-K
EX-99.2
9uzbzgzs
21 Dec 22
Other Events
5:25pm
424B5
8lngt5l 60
21 Dec 22
Prospectus supplement for primary offering
5:23pm